S. Ortiz, S. Pittock, A. Berthele, Michael Levy, I. Nakashima, C. O. Guevara, H. Kim
{"title":"抗水通道蛋白-4抗体阳性的成人神经脊髓炎视谱障碍患者在3期冠军赛- nmosd试验中的药代动力学和药效学(S5.004)","authors":"S. Ortiz, S. Pittock, A. Berthele, Michael Levy, I. Nakashima, C. O. Guevara, H. Kim","doi":"10.1212/wnl.0000000000203471","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":334567,"journal":{"name":"Sunday, April 23","volume":"86 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Pharmacokinetics and Pharmacodynamics of Ravulizumab in Adults with Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder During the Phase 3 CHAMPION-NMOSD trial (S5.004)\",\"authors\":\"S. Ortiz, S. Pittock, A. Berthele, Michael Levy, I. Nakashima, C. O. Guevara, H. Kim\",\"doi\":\"10.1212/wnl.0000000000203471\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":334567,\"journal\":{\"name\":\"Sunday, April 23\",\"volume\":\"86 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sunday, April 23\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1212/wnl.0000000000203471\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sunday, April 23","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/wnl.0000000000203471","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pharmacokinetics and Pharmacodynamics of Ravulizumab in Adults with Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder During the Phase 3 CHAMPION-NMOSD trial (S5.004)